14
Dec
2026
Zeta Pharma
Exhibitor at CPHI Middle East 2026 stand H1.U10
About Us
Categories
-
Country/Region:Egypt
-
On CPHI since:2019
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
Contact info
-
-
36 Al Sheikh Mohammad Al Nadl St., Off Mostafa, Cairo, Egypt
Event information
CPHI Middle East 2026
-
14 Dec 2026 - 16 Dec 2026
-
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
-
Visit us at stand H1.U10
Products Featured at CPHI Middle East 2026
-
Product Elimbosis-Apixaban
Composition Each Elimbosis 2.5mg Film tablet contains: apixaban .......................... 5 mg Each Elimbosis 2.5mg Film tablet contains: apixaban .......................... 2.5 mg Therapeutic Indications ● Stroke Prophylaxis with Atrial Fibrillation ● Postoperative Prophylaxis of DVT/PE -DVT or PE Treatm... -
Product Empacoza-empagliflozin
empagliflozin.............................................. 10 mg empagliflozin.............................................. 25 mg Therapeutic Indications ● Type 2 Diabetes Mellitus ○ Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes ○ Also indicated t... -
Product Nexicure mups-Esomeprazole
Each Nexicure 40mg Film Coated MUPS tablet contains: Esomeprazole ...... 40 mg Each Nexicure 20mg Film Coated MUPS tablet contains: ......................................... 20 mg Therapeutic Indications ● Gastroesophageal reflux disease’ (GERD) ● Erosive reflux oesophagitis. ● Treatment of Zollinger-Ellis... -
Product Nexicure - esomeprazole 40 mg and 20 mg MUPS tab
Nexicure 40 mg and 20mg MUPS tabPack: 20 tab
Category: proton pump inhibitors (PPIs)The first and only PPI - Esmoperazole 40 mg and 20mg tab generic with MUPS technology
Indication: It is used to treat gastroesophageal reflux disease GERD, peptic ulcer disease, and&nbs... -
Product Vonseca - vonoprazan 10mg and 20 mg tab
Vonoprazan is a potassium-competitive acid blocker (PCAB). It competitively inhibits the binding of K ions to hydrogen/potassium-adenosine triphosphate (H+/K+-ATPase) enzyme system that acts as the proton pump of the gastric parietal cell, thereby inhibiting gastric acid production belong to the prot...
Zeta Pharma Resources (1)
-
Brochure Zeta Pharma Company Profile
ZETA PHARMA® is the leading branded generic from Egypt
ZETA PHARMA®, established in 2010, brings significant value to the pharmaceutical industry in Egypt, Africa, Middle East and CIS regions.
ZETA PHARMA® is the fastest-growing company in the top 100 Egyptian pharmaceutical companies during the last 4 years with CAGR % 112 ( IQVIA.)
ZETA PHARMA® boasts a state-of-the-art manufacturing facility built to WHO cGMP standards.
ZETA PHARMA®, in a groundbreaking partnership with the European Bank for Reconstruction and Development (EBRD), has embarked on an ambitious project to secure EMA accreditation. This endeavor underscores our unwavering commitment to excellence and innovation, setting new standards in the pharmaceutical industry.
ZETA PHARMA®, offer advanced manufacturing meets cutting-edge pharmaceutical solutions, empowering health and wellness across the globe...